These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

293 related items for PubMed ID: 30834518

  • 1. Deregulated GATA6 modulates stem cell-like properties and metabolic phenotype in hepatocellular carcinoma.
    Tan HW, Leung CO, Chan KK, Ho DW, Leung MS, Wong CM, Ng IO, Lo RC.
    Int J Cancer; 2019 Oct 01; 145(7):1860-1873. PubMed ID: 30834518
    [Abstract] [Full Text] [Related]

  • 2. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.
    Yin X, Zhang BH, Zheng SS, Gao DM, Qiu SJ, Wu WZ, Ren ZG.
    J Hematol Oncol; 2015 Mar 11; 8():23. PubMed ID: 25879771
    [Abstract] [Full Text] [Related]

  • 3. HOXB7 accelerates the malignant progression of hepatocellular carcinoma by promoting stemness and epithelial-mesenchymal transition.
    Huan HB, Yang DP, Wen XD, Chen XJ, Zhang L, Wu LL, Bie P, Xia F.
    J Exp Clin Cancer Res; 2017 Jun 24; 36(1):86. PubMed ID: 28646927
    [Abstract] [Full Text] [Related]

  • 4. E3 ligase ZFP91 inhibits Hepatocellular Carcinoma Metabolism Reprogramming by regulating PKM splicing.
    Chen D, Wang Y, Lu R, Jiang X, Chen X, Meng N, Chen M, Xie S, Yan GR.
    Theranostics; 2020 Jun 24; 10(19):8558-8572. PubMed ID: 32754263
    [Abstract] [Full Text] [Related]

  • 5. BORIS up-regulates OCT4 via histone methylation to promote cancer stem cell-like properties in human liver cancer cells.
    Liu Q, Chen K, Liu Z, Huang Y, Zhao R, Wei L, Yu X, He J, Liu J, Qi J, Qin Y, Li B.
    Cancer Lett; 2017 Sep 10; 403():165-174. PubMed ID: 28645561
    [Abstract] [Full Text] [Related]

  • 6. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.
    Hermann PC, Sancho P, Cañamero M, Martinelli P, Madriles F, Michl P, Gress T, de Pascual R, Gandia L, Guerra C, Barbacid M, Wagner M, Vieira CR, Aicher A, Real FX, Sainz B, Heeschen C.
    Gastroenterology; 2014 Nov 10; 147(5):1119-33.e4. PubMed ID: 25127677
    [Abstract] [Full Text] [Related]

  • 7. Let-7 inhibits self-renewal of hepatocellular cancer stem-like cells through regulating the epithelial-mesenchymal transition and the Wnt signaling pathway.
    Jin B, Wang W, Meng XX, Du G, Li J, Zhang SZ, Zhou BH, Fu ZH.
    BMC Cancer; 2016 Nov 08; 16(1):863. PubMed ID: 27821157
    [Abstract] [Full Text] [Related]

  • 8. BPTF promotes hepatocellular carcinoma growth by modulating hTERT signaling and cancer stem cell traits.
    Zhao X, Zheng F, Li Y, Hao J, Tang Z, Tian C, Yang Q, Zhu T, Diao C, Zhang C, Chen M, Hu S, Guo P, Zhang L, Liao Y, Yu W, Chen M, Zou L, Guo W, Deng W.
    Redox Biol; 2019 Jan 08; 20():427-441. PubMed ID: 30419422
    [Abstract] [Full Text] [Related]

  • 9. HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition.
    Xu J, Zhang X, Wang H, Ge S, Gao T, Song L, Wang X, Li H, Qin Y, Zhang Z.
    Biomed Pharmacother; 2017 Apr 08; 88():421-429. PubMed ID: 28122307
    [Abstract] [Full Text] [Related]

  • 10. Role of IQGAP3 in metastasis and epithelial-mesenchymal transition in human hepatocellular carcinoma.
    Shi Y, Qin N, Zhou Q, Chen Y, Huang S, Chen B, Shen G, Jia H.
    J Transl Med; 2017 Aug 15; 15(1):176. PubMed ID: 28810875
    [Abstract] [Full Text] [Related]

  • 11. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
    Huang JY, Zhang K, Chen DQ, Chen J, Feng B, Song H, Chen Y, Zhu Z, Lu L, De W, Wang R, Chen LB.
    Oncotarget; 2015 Jul 30; 6(21):18613-30. PubMed ID: 26164082
    [Abstract] [Full Text] [Related]

  • 12. Downregulation of RFX1 predicts poor prognosis of patients with small hepatocellular carcinoma.
    Liu Y, Jiang P, Wang G, Liu X, Luo S.
    Eur J Surg Oncol; 2018 Jul 30; 44(7):1087-1093. PubMed ID: 29764705
    [Abstract] [Full Text] [Related]

  • 13. Secreted protein acidic and rich in cysteine promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells and acquisition of cancerstem cell phenotypes.
    Jiang X, Liu F, Wang Y, Gao J.
    J Gastroenterol Hepatol; 2019 Oct 30; 34(10):1860-1868. PubMed ID: 31041810
    [Abstract] [Full Text] [Related]

  • 14. IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met/Src signaling pathway.
    Huang WC, Tung SL, Chen YL, Chen PM, Chu PY.
    BMC Cancer; 2018 May 30; 18(1):609. PubMed ID: 29848298
    [Abstract] [Full Text] [Related]

  • 15. MicroRNA-125b attenuates epithelial-mesenchymal transitions and targets stem-like liver cancer cells through small mothers against decapentaplegic 2 and 4.
    Zhou JN, Zeng Q, Wang HY, Zhang B, Li ST, Nan X, Cao N, Fu CJ, Yan XL, Jia YL, Wang JX, Zhao AH, Li ZW, Li YH, Xie XY, Zhang XM, Dong Y, Xu YC, He LJ, Yue W, Pei XT.
    Hepatology; 2015 Sep 30; 62(3):801-15. PubMed ID: 25953743
    [Abstract] [Full Text] [Related]

  • 16. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
    Zhou M, Zhang XY, Yu X.
    Biomed Pharmacother; 2017 Jan 30; 85():348-354. PubMed ID: 27899259
    [Abstract] [Full Text] [Related]

  • 17. Transforming growth factor-β-induced plasticity causes a migratory stemness phenotype in hepatocellular carcinoma.
    Malfettone A, Soukupova J, Bertran E, Crosas-Molist E, Lastra R, Fernando J, Koudelkova P, Rani B, Fabra Á, Serrano T, Ramos E, Mikulits W, Giannelli G, Fabregat I.
    Cancer Lett; 2017 Apr 28; 392():39-50. PubMed ID: 28161507
    [Abstract] [Full Text] [Related]

  • 18. Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis.
    Wang Y, Liu Z, Yao B, Li Q, Wang L, Wang C, Dou C, Xu M, Liu Q, Tu K.
    Mol Cancer; 2017 Jul 17; 16(1):123. PubMed ID: 28716020
    [Abstract] [Full Text] [Related]

  • 19. Circular RNA circIPO11 drives self-renewal of liver cancer initiating cells via Hedgehog signaling.
    Gu Y, Wang Y, He L, Zhang J, Zhu X, Liu N, Wang J, Lu T, He L, Tian Y, Fan Z.
    Mol Cancer; 2021 Oct 14; 20(1):132. PubMed ID: 34649567
    [Abstract] [Full Text] [Related]

  • 20. Increased expression of SLC46A3 to oppose the progression of hepatocellular carcinoma and its effect on sorafenib therapy.
    Zhao Q, Zheng B, Meng S, Xu Y, Guo J, Chen LJ, Xiao J, Zhang W, Tan ZR, Tang J, Chen L, Chen Y.
    Biomed Pharmacother; 2019 Jun 14; 114():108864. PubMed ID: 30981107
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.